Literature DB >> 24440909

A novel role for the apoptosis inhibitor ARC in suppressing TNFα-induced regulated necrosis.

G Kung1, P Dai2, L Deng2, R N Kitsis1.   

Abstract

TNFα signaling can promote apoptosis or a regulated form of necrosis. ARC (apoptosis repressor with CARD (caspase recruitment domain)) is an endogenous inhibitor of apoptosis that antagonizes both the extrinsic (death receptor) and intrinsic (mitochondrial/ER) apoptosis pathways. We discovered that ARC blocks not only apoptosis but also necrosis. TNFα-induced necrosis was abrogated by overexpression of wild-type ARC but not by a CARD mutant that is also defective for inhibition of apoptosis. Conversely, knockdown of ARC exacerbated TNFα-induced necrosis, an effect that was rescued by reconstitution with wild-type, but not CARD-defective, ARC. Similarly, depletion of ARC in vivo exacerbated necrosis caused by infection with vaccinia virus, which elicits severe tissue damage through this pathway, and sensitized mice to TNFα-induced systemic inflammatory response syndrome. The mechanism underlying these effects is an interaction of ARC with TNF receptor 1 that interferes with recruitment of RIP1, a critical mediator of TNFα-induced regulated necrosis. These findings extend the role of ARC from an apoptosis inhibitor to a regulator of the TNFα pathway and an inhibitor of TNFα-mediated regulated necrosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24440909      PMCID: PMC3950326          DOI: 10.1038/cdd.2013.195

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  51 in total

Review 1.  Alternative cell death mechanisms in development and beyond.

Authors:  Junying Yuan; Guido Kroemer
Journal:  Genes Dev       Date:  2010-12-01       Impact factor: 11.361

2.  ARC, an apoptosis suppressor limited to terminally differentiated cells, is induced in human breast cancer and confers chemo- and radiation-resistance.

Authors:  I Mercier; M Vuolo; R Madan; X Xue; A J Levalley; A W Ashton; J-F Jasmin; M T Czaja; E Y Lin; R C Armstrong; J W Pollard; R N Kitsis
Journal:  Cell Death Differ       Date:  2005-06       Impact factor: 15.828

3.  cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination.

Authors:  Mathieu J M Bertrand; Snezana Milutinovic; Kathleen M Dickson; Wai Chi Ho; Alain Boudreault; Jon Durkin; John W Gillard; James B Jaquith; Stephen J Morris; Philip A Barker
Journal:  Mol Cell       Date:  2008-06-20       Impact factor: 17.970

Review 4.  Cell death in the pathogenesis of heart disease: mechanisms and significance.

Authors:  Russell S Whelan; Vladimir Kaplinskiy; Richard N Kitsis
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

5.  Induction of the apoptosis inhibitor ARC by Ras in human cancers.

Authors:  Lily Wu; Young-Jae Nam; Gloria Kung; Michael T Crow; Richard N Kitsis
Journal:  J Biol Chem       Date:  2010-04-14       Impact factor: 5.157

Review 6.  Molecular mechanisms of necroptosis: an ordered cellular explosion.

Authors:  Peter Vandenabeele; Lorenzo Galluzzi; Tom Vanden Berghe; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2010-09-08       Impact factor: 94.444

7.  RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis.

Authors:  Duan-Wu Zhang; Jing Shao; Juan Lin; Na Zhang; Bao-Ju Lu; Sheng-Cai Lin; Meng-Qiu Dong; Jiahuai Han
Journal:  Science       Date:  2009-06-04       Impact factor: 47.728

Review 8.  Necroptosis as an alternative form of programmed cell death.

Authors:  Dana E Christofferson; Junying Yuan
Journal:  Curr Opin Cell Biol       Date:  2010-01-04       Impact factor: 8.382

9.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

10.  Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.

Authors:  Sudan He; Lai Wang; Lin Miao; Tao Wang; Fenghe Du; Liping Zhao; Xiaodong Wang
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

View more
  10 in total

1.  Synthesis, Characterization, and DNA Binding Profile of a Macrocyclic β-Sheet Analogue of ARC Protein.

Authors:  Azzurra Stefanucci; Jesús Mosquera; Eugènio Vázquez; José L Mascareñas; Ettore Novellino; Adriano Mollica
Journal:  ACS Med Chem Lett       Date:  2015-10-29       Impact factor: 4.345

2.  Expression of the apoptosis repressor with caspase recruitment domain (ARC) in liver metastasis of colorectal cancer and its correlation with DNA mismatch repair proteins and p53.

Authors:  Csaba Tóth; Jeannine Meinrath; Esther Herpel; Jutta Derix; Jochen Fries; Reinhard Buettner; Peter Schirmacher; Sebastian Heikaus
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-31       Impact factor: 4.553

3.  Apoptosis Repressor With Caspase Recruitment Domain Ameliorates Amyloid-Induced β-Cell Apoptosis and JNK Pathway Activation.

Authors:  Andrew T Templin; Tanya Samarasekera; Daniel T Meier; Meghan F Hogan; Mahnaz Mellati; Michael T Crow; Richard N Kitsis; Sakeneh Zraika; Rebecca L Hull; Steven E Kahn
Journal:  Diabetes       Date:  2017-07-20       Impact factor: 9.461

4.  Loss of apoptosis repressor with caspase recruitment domain (ARC) worsens high fat diet-induced hyperglycemia in mice.

Authors:  Andrew T Templin; Christine Schmidt; Meghan F Hogan; Nathalie Esser; Richard N Kitsis; Rebecca L Hull; Sakeneh Zraika; Steven E Kahn
Journal:  J Endocrinol       Date:  2021-09-20       Impact factor: 4.669

5.  Crystal structure of caspase recruiting domain (CARD) of apoptosis repressor with CARD (ARC) and its implication in inhibition of apoptosis.

Authors:  Tae-ho Jang; Seong Hyun Kim; Jae-Hee Jeong; Sunghwan Kim; Yeon-Gil Kim; Yeun Gil Kim; Hyun Ho Park
Journal:  Sci Rep       Date:  2015-06-03       Impact factor: 4.379

6.  A myeloid tumor suppressor role for NOL3.

Authors:  Robert F Stanley; Richard T Piszczatowski; Boris Bartholdy; Kelly Mitchell; Wendy M McKimpson; Swathi Narayanagari; Dagmar Walter; Tihomira I Todorova; Cassandra Hirsch; Hideki Makishima; Britta Will; Christine McMahon; Kira Gritsman; Jaroslaw P Maciejewski; Richard N Kitsis; Ulrich Steidl
Journal:  J Exp Med       Date:  2017-02-23       Impact factor: 14.307

7.  ARC regulates programmed necrosis and myocardial ischemia/reperfusion injury through the inhibition of mPTP opening.

Authors:  Tao Xu; Wei Ding; Xiang Ao; Xianming Chu; Qinggong Wan; Yu Wang; Dandan Xiao; Wanpeng Yu; Mengyang Li; Fei Yu; Jianxun Wang
Journal:  Redox Biol       Date:  2018-11-02       Impact factor: 11.799

8.  Targeting Germ Cell Tumors with the Newly Synthesized Flavanone-Derived Compound MLo1302 Efficiently Reduces Tumor Cell Viability and Induces Apoptosis and Cell Cycle Arrest.

Authors:  João Lobo; Ana Rita Cardoso; Vera Miranda-Gonçalves; Leendert H J Looijenga; Marie Lopez; Paola B Arimondo; Rui Henrique; Carmen Jerónimo
Journal:  Pharmaceutics       Date:  2021-01-07       Impact factor: 6.321

9.  Apoptosis repressor with caspase recruitment domain (ARC) promotes bone regeneration of bone marrow-derived mesenchymal stem cells by activating Fgf-2/PI3K/Akt signaling.

Authors:  Longwei Hu; Yang Wang; Hongya Pan; Kathreena Kadir; Jin Wen; Siyi Li; Chenping Zhang
Journal:  Stem Cell Res Ther       Date:  2021-03-16       Impact factor: 6.832

Review 10.  Role of apoptosis repressor with caspase recruitment domain (ARC) in cancer.

Authors:  Zhongjie Yu; Qi Li; Yi An; Xiatian Chen; Ziqian Liu; Zhe Li; Jinning Gao; Lynn Htet Htet Aung; Peifeng Li
Journal:  Oncol Lett       Date:  2019-10-11       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.